| Financial Year |
March 31 2023 |
| Monetary Funds |
745,536,835.63 |
| Held-for-trading Financial Assets |
980,000.00 |
| Notes Receivable |
98,533,832.95 |
| Accounts Receivable |
1,729,141,916.92 |
| Advances to Suppliers |
307,886,252.47 |
| Other Receivables |
53,350,031.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,493,242,314.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
154,932.00 |
| Other Current Assets |
385,087,329.42 |
| Total Current Assets |
5,626,391,176.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,878,315.82 |
| Long-term Equity Investment |
41,411,570.42 |
| Investment Properties |
-- |
| Fixed Assetes |
3,623,792,151.30 |
| Under-construction Projects |
2,094,308,413.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
696,588,844.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,352,026.75 |
| Deferred Income Tax Assets |
89,497,281.57 |
| Other Non-Current Assets |
192,630,892.41 |
| Sub-Total of Non-Current Assets |
6,806,529,646.23 |
| Total Assets |
12,432,920,822.24 |
| Short-Term Loans |
210,241,541.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
644,590,821.69 |
| Accounts Payable |
684,094,467.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,501,515.31 |
| Taxes Payable |
40,554,985.59 |
| Interest Payable |
-- |
| Dividend Payable |
9,837,572.17 |
| Other payables |
196,719,704.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
358,446,610.56 |
| Other Current Liabilities |
13,729,779.31 |
| Sub-Total of Current Liabilities |
2,311,157,214.43 |
| Long-term Loans |
601,761,151.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
300,500,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
77,285,748.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,245,265,299.93 |
| Total Liabilities |
3,556,422,514.36 |
| Paid-In Capital(Or Share Stock) |
782,876,800.00 |
| Capital Surplus |
2,666,642,131.99 |
| Surplus Reserve |
349,014,639.01 |
| LESS:Treasury Stock |
89,100,000.00 |
| Undistributed Profits |
4,883,810,739.40 |
| Minority Stockholder's Interest |
261,807,529.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,614,690,778.05 |
| Owner's Equity（Stockholder's Equity） |
8,876,498,307.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,432,920,822.24 |
